JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M602743200 on August 10, 2006

J. Biol. Chem., Vol. 281, Issue 42, 31854-31862, October 20, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/42/31854    most recent
M602743200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mellody, K. T.
Right arrow Articles by Kielty, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mellody, K. T.
Right arrow Articles by Kielty, C. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Marfan Syndrome-causing Mutations in Fibrillin-1 Result in Gross Morphological Alterations and Highlight the Structural Importance of the Second Hybrid Domain*

Kieran T. Mellody{ddagger}, Lyle J. Freeman{ddagger}, Clair Baldock{ddagger}1, Thomas A. Jowitt{ddagger}, Veronique Siegler§2, Bertrand D. E. Raynal{ddagger}, Stuart A. Cain{ddagger}, Tim J. Wess§2, C. Adrian Shuttleworth{ddagger}, and Cay M. Kielty{ddagger}3

From the {ddagger}Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom and the §School of Optometry and Vision Sciences, Redwood Building, King Edward VIII Avenue, University of Cardiff, CF10 3NB, United Kingdom

Mutations in fibrillin-1 result in Marfan syndrome, which affects the cardiovascular, skeletal and ocular systems. The multiorgan involvement and wide spectrum of associated phenotypes highlights the complex pathogenesis underlying Marfan syndrome. To elucidate the genotype to phenotype correlations, we engineered four Marfan syndrome causing mutations into a fibrillin-1 fragment encoded by exons 18-25, a region known to interact with tropoelastin. Biophysical and biochemical approaches, including small angle x-ray scattering, analytical ultracentrifugation, and circular dichroism, were used to study the impact of these mutations upon the structure and function of the protein. Mutations G880S, C862R, and C908R, situated within the second hybrid domain, disrupted the ratio of {alpha}-helix to beta-sheet leading to a more compact conformation. These data clearly demonstrate the importance of the previously uncharacterized hybrid domain in fibrillin-1 structure. In contrast, mutation K1023N situated within the linker region between the third eight cysteine motif and cbEGF 11 markedly extended the length of the fragment. However, none of the mutations affected tropoelastin binding. The profound effects of all four mutations on fragment conformation suggest that they contribute to the pathogenesis of Marfan syndrome by disrupting protein folding and its assembly into fibrillin-rich microfibrils.


Received for publication, March 23, 2006 , and in revised form, July 11, 2006.

* This work was funded in part by the British Heart Foundation, Medical Research Council (UK) and EU Grant LSHM-CT-2005-018960. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Recipient of a Royal Society Olga Kennard research fellowship.

2 Recipient of Biotechnology and Biological Sciences Research Council Grant 98/S15326.

3 A Royal Society-Wolfson Research Merit Award holder. To whom correspondence should be addressed: Faculty of Life Sciences, University of Manchester, Manchester, M13 9PT. Tel.: 44-161-275-5739; Fax: 44-161-275-5082; E-mail: cay.kielty{at}manchester.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. A. Cain, A. K. Baldwin, Y. Mahalingam, B. Raynal, T. A. Jowitt, C. A. Shuttleworth, J. R. Couchman, and C. M. Kielty
Heparan Sulfate Regulates Fibrillin-1 N- and C-terminal Interactions
J. Biol. Chem., October 3, 2008; 283(40): 27017 - 27027.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. V. Bax, Y. Mahalingam, S. Cain, K. Mellody, L. Freeman, K. Younger, C. A. Shuttleworth, M. J. Humphries, J. R. Couchman, and C. M. Kielty
Cell adhesion to fibrillin-1: identification of an Arg-Gly-Asp-dependent synergy region and a heparin-binding site that regulates focal adhesion formation
J. Cell Sci., April 15, 2007; 120(8): 1383 - 1392.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.